Clinical Trials for Metastatic or Locally Advanced Unresectable Solid Tumors

Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)

NCT ID: NCT05396833

This clinical trial is studying a new treatment approach for patients with metastatic or locally advanced solid tumors that cannot be surgically removed. The trial is looking at a medication called...